Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Salaries and benefits

Supplies

Other operating expenses

Equity in earnings of affiliates

Depreciation and amortization

Interest expense

Gains on sales of facilities

Losses on retirement of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

HCA Healthcare

HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. The firm operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was founded by Dr. Thomas F. Frist, Jr in 1968 and is headquartered in Nashville, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

HCA Healthcare reports robust Q4 performance and outlines strategic growth

HCA Healthcare's Q4 2022 performance reflects strong same-facility volumes, stable labor costs, and strategic investments in growth areas.
The company's focus on overcoming challenges, leveraging strengths, and seizing opportunities positions them for sustainable growth and operational excellence.
With a clear agenda for 2023, including revenue guidance and investment plans, HCA Healthcare aims to navigate market dynamics and drive value creation.
By addressing key performance metrics, managing costs effectively, and pursuing strategic initiatives, HCA Healthcare demonstrates a commitment to long-term success.

HCA Healthcare reports robust Q1 earnings amidst operational enhancements

HCA Healthcare delivered strong financial performance with notable growth in key metrics and operational efficiency improvements.
While facing challenges from COVID-related impacts and procedural shifts, the company is focused on maintaining positive volume trends and managing costs effectively.
Opportunities lie in investing in capabilities, capacity improvement, and navigating contract renewals in an inflationary environment.

HCA Healthcare reports robust Q2 earnings amidst strategic investments

HCA Healthcare's Q2 2023 performance reflects strong earnings, revenue growth, and cash flow, supported by strategic investments.
While facing challenges like margin impact from acquisitions and rising capital spending, the company is well-positioned for growth.
Opportunities lie in optimizing labor costs, expanding services, and leveraging positive payer mix trends for sustained success.
Overall, HCA's focus on quality care, financial prudence, and growth initiatives underpins a positive outlook for the future.

HCA Healthcare manages challenges, eyes sustained growth amid revenue optimizations

HCA Healthcare navigated challenges from the Valesco venture to deliver solid financial performance. The company's focus on quality care, cost management, and revenue optimization positions it for sustained growth. Anticipation of improved margins, strategic growth discussions, and operational enhancements highlight a positive outlook for the future.

HCA Healthcare reports robust Q4 earnings and outlines growth strategies

HCA Healthcare's strong Q4 performance and strategic investments position it well for growth in 2024, with a focus on cost management and operational efficiency.
The company's confidence in navigating industry challenges, coupled with initiatives to drive value and improve patient outcomes, underpin its optimistic outlook for the future.
With a clear focus on growth drivers like Medicare Advantage admissions and revenue per equivalent admission, HCA Healthcare is poised for a promising year ahead.

HCA Healthcare posts robust Q1 earnings, eyes sustained growth opportunities

HCA Healthcare's Q1 2024 performance reflects strong financial results and operational efficiency, supported by favorable same-facility volumes and effective cost management. While facing challenges in outpatient cases, the company is well-positioned to capitalize on opportunities for growth.
Strategic investments in infrastructure, technology, and campus integration are strengthening HCA Healthcare's operational capabilities and market positioning. Monitoring Medicaid statuses and potential procedure rebounds are key focus areas for the company.

HCA Healthcare reports robust Q2 earnings amidst market challenges

HCA Healthcare's Q2 2024 performance reflects strong financial growth, driven by increased revenues and improved margins.
While challenges like managing capital expenditures persist, opportunities in payer mix optimization and market demand offer avenues for further growth.
The company's ability to navigate evolving market dynamics and capitalize on strategic opportunities will be key to sustaining its positive momentum.

HCA Healthcare reports resilient Q3 results amid hurricane challenges

HCA Healthcare's Q3 performance showcased resilience amidst hurricane challenges, with strong volume and revenue growth.
Investments in network expansion and technology underscore the company's commitment to quality care and operational efficiency.
While challenges from hurricanes persist, HCA Healthcare sees opportunities for earnings growth and value creation in the near future.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ADMA Biologics

Exelixis

HCA Healthcare (HCA), ADMA Biologics (ADMA) and Exelixis (EXEL) are three medical stocks that you can look into as the sector continues to sustain its end-of-the-year momentum.

3 Medical Stocks to Buy as the Sector Continues to Grow

American Eagle Outfitters

North American Energy Partners

Industrial Select Sector SPDR Fund

Health Care Select Sector SPDR Fund

SPDR S&P Retail ETF

The U.S. economy added 353,000 for the month, much better than the Dow Jones estimate for 185,000 (as quoted on CNBC).

3 Sector ETFs & Stocks to Bet on Superb January Jobs Data

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced the HCA Healthcare Hope Fund, a 501(c)3 public charity that provides emergency funds to colleagues when significant hardships arise due to illness, injury, natural disasters or other difficult situations, has surpassed $100 million in grants awarded since its founding in 2005. In 2023 alone, more than $11.4 million in assistance was distributed to help more than.

HCA Healthcare Announces the HCA Healthcare Hope Fund Has Awarded $100 Million in Grants to Colleagues in Need

Axos Financial Inc.

Eagle Materials

Powell Industries

Invest in stocks such as HCA Healthcare (HCA), Powell Industries (POWL), Axos Financial (AX), and Eagle Materials (EXP) for solid earnings growth.

4 Top Stocks to Buy for Attractive Earnings Growth

Does HCA Healthcare (HCA) have what it takes to be a top stock pick for momentum investors? Let's find out.

HCA Healthcare (HCA) Is Up 9.17% in One Week: What You Should Know

HCA Healthcare Inc. NYSE: HCA is the largest for-profit hospital company in the United States. The company owns and operates 186 hospitals and nearly 2,400 ambulatory sites, including freestanding emergency rooms, urgent care and surgery centers, and physician clinics in 20 states and the United Kingdom.

Is Humana's pain HCA Healthcare's gain?

Buyback Bonanza: 3 Buy-Rated Companies Scooping Up Shares

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Chad Wasserman, a nearly 30-year veteran of the company, has been appointed senior vice president and chief information officer, effective February 1, 2024. Wasserman succeeds P. Martin “Marty” Paslick, who is retiring after 38 years with HCA Healthcare. As chief information officer, Wasserman will lead more than 6,700 colleagues in the Information Technolog.

HCA Healthcare Names Chad Wasserman as Chief Information Officer

Bank of New York Mellon

Hookipa Pharma Inc

BK, HCA and HOOK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 2, 2023.

Best Momentum Stocks to Buy for February 2nd

Coca-Cola Femsa SAB de CV

United States Cellular

USM, BK, KOF, HCA and AX have been added to the Zacks Rank #1 (Strong Buy) List on February 2, 2023.

New Strong Buy Stocks for February 2nd

Oshkosh

PulteGroup

Stronger-than-expected Q4 earnings on Tuesday helped rectify the notion that these stocks are undervalued making now an ideal time to buy.

3 Value Stocks to Buy After Beating Q4 Earnings Expectations

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that 54 of its hospitals were recognized on the 2024 Healthgrades America's 250 Best Hospitals list for superior performance in providing care for conditions and procedures across multiple specialty lines and areas. Using a methodology focused solely on patient outcomes, this award recognizes the top 5% of hospitals in the country for clinical excellence. “We str.

54 HCA Healthcare Hospitals Recognized as “America's Best Hospitals” by Healthgrades

HCA Healthcare, Inc. (HCA) Q4 2023 Earnings Call Transcript

HCA Healthcare (HCA) expects EPS in the range of $19.70-$21.20 for 2024, the midpoint being 7.6% higher than the 2023 figure.

HCA Healthcare's (HCA) Q4 Earnings Beat on Improved Admissions

Although the revenue and EPS for HCA (HCA) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

HCA (HCA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

HCA Healthcare (HCA) came out with quarterly earnings of $5.90 per share, beating the Zacks Consensus Estimate of $5.05 per share. This compares to earnings of $4.64 per share a year ago.

HCA Healthcare (HCA) Beats Q4 Earnings and Revenue Estimates

Shares of HCA Healthcare Inc. HCA, +1.16% jumped about 6% premarket on Tuesday after the hospital operator reported fourth-quarter results that beat expectations, amid continued growth in inpatient and outpatient procedures.

HCA's stock jumps as fourth-quarter results top expectations

HCA Healthcare on Tuesday forecast 2024 profit above Wall Street estimates as the largest U.S. for-profit hospital operator anticipated strong demand for medical procedures, sending its shares up 6% in premarket trading.

HCA Healthcare forecasts 2024 profit above Street estimates

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2023. Key fourth quarter metrics (all percentage changes compare 4Q 2023 to 4Q 2022 unless otherwise noted): Revenues totaled $17.303 billion Net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share Adjusted EBITDA totaled $3.618 billion Cash flows from operating activities totaled $2.674 billion S.

HCA Healthcare Reports Fourth Quarter 2023 Results and Provides 2024 Guidance

HCA Healthcare (HCA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for HCA Healthcare (HCA) This Earnings Season?

Chipotle

Eaton

Lennox International

Parker-Hannifin

We have narrowed our search to five growth stocks that are poised to beat on earnings results next week. These are: PH, CMG, ETN, HCA, LII.

5 Growth Stocks to Buy That Are Poised to Beat on Earnings

The latest trading day saw HCA Healthcare (HCA) settling at $283.43, representing a -0.91% change from its previous close.

HCA Healthcare (HCA) Declines More Than Market: Some Information for Investors

Beyond analysts' top -and-bottom-line estimates for HCA (HCA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

HCA (HCA) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

HCA Healthcare's (HCA) fourth-quarter results are likely to reflect increased admissions and a lower average length of stay.

Can Higher Costs Affect HCA Healthcare's (HCA) Q4 Earnings?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

News for HCA Healthcare Stock (HCA)